Related by context. Frequent words. (Click for all words.) 79 Metastatic Colorectal Cancer 77 Advanced Prostate Cancer 75 Chronic Lymphocytic Leukemia 75 Metastatic Melanoma 75 Chronic Hepatitis C 75 Monotherapy 75 Combination Therapy 75 Clinical Trial Results 74 Well Tolerated 74 Elderly Patients 73 Pulmonary Arterial Hypertension 73 Preclinical Data 73 Phase III Clinical Trial 73 Drug Candidate 72 Patients Treated 72 Overactive Bladder 72 Solid Tumors 72 Bevacizumab 72 Epratuzumab 72 Diabetic Patients 71 Bladder Cancer 71 Carcinoma 71 Chronic Heart Failure 71 Pivotal Trial 71 Phase III Trial 71 Heart Failure Patients 71 Autoimmune Diseases 71 Completes Enrollment 71 Monoclonal Antibody 71 Rheumatoid Arthritis RA 70 Benign Prostatic Hyperplasia 70 Patient Enrollment 70 Meta Analysis 70 Postmenopausal Women 70 Prostate Cancer Patients 70 Metastatic Breast Cancer 70 Trastuzumab 70 Relapsed 70 Cardiovascular Events 70 Pivotal Phase III 70 Dasatinib 69 Natalizumab 69 Drug Resistant 69 Small Molecule 69 Low Dose 69 Gemcitabine 69 Ischemic 69 Atopic Dermatitis 69 Anti TNF 69 Diabetic Macular Edema 69 J Am Coll 68 Insulin Resistance 68 Irinotecan 68 Breast Cancer Patients 68 Bortezomib 68 Lenalidomide 68 Pirfenidone 68 Targeted Therapy 68 Pivotal Phase 68 J Am Acad 67 Panzem R 67 Gemzar ® 67 DOXIL 67 luteinizing hormone releasing 67 Tolerability 67 Breast Cancer Treatment 67 Voreloxin 67 metastatic castration resistant 67 Bavituximab 67 metastatic hormone refractory 67 Study Demonstrates 67 Genasense R 67 Traficet EN 67 Presents Positive 67 Inhibits 67 Urinary Incontinence 67 Liver Cancer 67 Hepatitis C Virus 67 Prostate Cancer Treatment 67 Metastatic 66 Early Diagnosis 66 leukemia CLL 66 Acute Myeloid Leukemia AML 66 FDA Clearance 66 Doxorubicin 66 Regimens 66 Cell Lung Cancer 66 relapsing multiple sclerosis 66 Hormone Therapy 66 PsA 66 Enoxaparin 66 Cancer Cells 66 Amrubicin 66 Positive Opinion 66 EZN 66 Cardiol 66 Peripheral Artery Disease 66 Systemic Lupus Erythematosus 66 Cardiac Resynchronization Therapy 66 Increased Risk 66 Glioma